Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia
Abstract Quantification of measurable residual disease (MRD) provides critical prognostic information in acute myeloid leukemia (AML). A variety of platforms exist for MRD detection, varying in their sensitivity and applicability to individual patients. MRD detected by quantitative polymerase chain...
Main Authors: | Marisa J. L. Aitken, Farhad Ravandi, Keyur P. Patel, Nicholas J. Short |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13045-021-01148-5 |
Similar Items
-
Acute Myeloid Leukemia (AML) as a model for cancer therapy
by: Farhad eRavandi
Published: (2012-10-01) -
Angiogenesis and Minimal Residual Disease in Patients with Acute Myeloid Leukemia
by: Pardis Nematollahi, et al.
Published: (2020-04-01) -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
by: Maria Ilaria Del Principe
Published: (2016-10-01) -
Quality of Response in Acute Myeloid Leukemia: The Role of Minimal Residual Disease
by: Luca Maurillo, et al.
Published: (2019-09-01) -
Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances
by: Cumbo C, et al.
Published: (2020-05-01)